To learn more about this report, request sample copy
North America dominates the global urine collection devices market with an estimated market share of 41.2 % in 2024. The region has a well-established healthcare infrastructure and high healthcare spending. Many leading manufacturers of urine collection devices are headquartered in the U.S. and Canada, giving the region an edge in terms of innovative product development. Moreover, rising geriatric population prone to urological disorders can boost demand.
Stringent regulations regarding patient safety and product quality ensures the availability of high-grade medical products. This has helped North America to emerge as a major production and export hub. Several medical device companies are focusing on the U.S. through strategic deals and collaborations with local players to leverage the large market opportunities.
Asia Pacific is projected to be the fastest growing regional market. Rapid economic development, growing medical tourism, increasing healthcare expenditure and massive unmet needs boosts the uptake of urine collection devices across developing countries.
China and India represent major manufacturing and export hubs, owing to low-cost skilled labor and favorable business regulations promoting foreign investments. Domestic demand is also augmented by rising incidence of lifestyle diseases, expanding medical infrastructure and large patient pools.
Pricing pressure from local generic counterparts remains a challenge for prominent brands. To succeed in the price-sensitive APAC markets, companies are investing in cost-effective technology and collaborative research with regional diagnostic labs and hospitals. The steady influx of private capital into the healthcare sector will additionally stimulate regional demand.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients